Akihiko Izumi
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Treatment outcomes of adult B-cell ALL with post-transplant relapse in the era of immunotherapeutic agents.
Journal: Transplantation and cellular therapy
Published: March 24, 2026
Personalized multivariable clinical prognostic model for patients with acute myeloid leukemia receiving intensive chemotherapy.
Journal: International journal of hematology
Published: December 25, 2025
Successful treatment of relapsed FLT3-mutated donor cell-derived MDS/AML with FLT3 inhibitor gilteritinib.
Journal: Annals of hematology
Published: September 29, 2025
Safety and efficacy of clofarabine for preconditioning intervention in patients undergoing allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphoblastic leukemia.
Journal: International journal of hematology
Published: September 19, 2025
Impact of venetoclax trough levels on safety and efficacy in the treatment of acute myeloid leukemia.
Journal: Scientific reports
Published: June 28, 2025
Impact of prior solid tumors and their treatment modality on outcomes after allogeneic hematopoietic stem cell transplantation.
Journal: Bone marrow transplantation
Published: May 05, 2025
Prognostic Value of C-Reactive Protein/Platelet Ratio as a Biomarker Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Malignant Lymphoma.
Journal: Hematological oncology
Published: February 10, 2025
Comparison of clinical outcomes between preemptive and maintenance therapy after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.
Journal: International journal of hematology
Published: January 09, 2025
Clinical significance of C-reactive protein/platelet ratio from diagnosis to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
Journal: Annals of hematology
Published: January 06, 2025
Preconditioning intervention prior to allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia.
Journal: Experimental hematology
Published: December 05, 2024
Successful treatment with venetoclax and azacitidine for extramedullary relapse of acute myeloid leukemia after cord blood transplantation
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: November 06, 2024
Last Updated: 09/26/2026